Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/200292
Title: | The EHA Research Roadmap: Malignant Lymphoid Diseases |
Author: | Dreyling, Martin André, Marc Gökbuget, Nicola Tilly, Hervé Jerkeman, Mats Gribben, John Ferreri, Andrés Morel, Pierre Stilgenbauer, Stephan Fox, Christopher Ribera, Josep Maria Zweegman, Sonja Aurer, Igor Bödör, Csaba Burkhardt, Birgit Buske, Christian Caballero, Maria Dolores Campo, Elías Chapuy, Bjoern Davies, Andrew Leval, Laurence de Doorduijn, Jeanette Federico, Massimo Gaulard, Philippe Gay, Francesca Ghia, Paolo Grønbæk, Kirsten Goldschmidt, Hartmut Kersten, Marie Jose Kiesewetter, Barbara3 Landman-Parker, Judith Gouill, Steven le Lenz, Georg Leppä, Sirpa López Guillermo, Armando Macintyre, Elizabeth Mateos Mantega, Maria Victoria Moreau, Philippe Moreno, Carol Nadel, Bertrand Okosun, Jessica Owen, Roger Pospisilova, Sarka Pott, Christiane Robak, Tadeusz Spina, Michelle Stamatopoulos, Kostas Stary, Jan Tarte, Karin Tedeschi, Allessandra Thieblemont, Catherine Trappe, Ralf Ulrich Trümper, Lorenz H. Salles, Gilles |
Keywords: | Malalties del sistema limfàtic Investigació mèdica Lymphatic diseases Medicine research |
Issue Date: | Jun-2022 |
Publisher: | Wolters Kluwer |
Abstract: | In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 iming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cellbased Immune Therapies; and Gene Therapy. © 2022 Wolters Kluwer Health. All rights reserved. |
Note: | Reproducció del document publicat a: https://doi.org/10.1097/HS9.0000000000000726 |
It is part of: | Hemasphere, 2022, 6, 6, e726-NA |
URI: | http://hdl.handle.net/2445/200292 |
Related resource: | https://doi.org/10.1097/HS9.0000000000000726 |
ISSN: | Dreyling M;André M;Gökbuget N;Tilly H;Jerkeman M;Gribben J;Ferreri A;Morel P;Stilgenbauer S;Fox C;Maria Ribera J;Zweegman S;Aurer I;Bödör C;Burkhardt B;Buske C;Dollores Caballero M;Campo E;Chapuy B;Davies A;De Leval L;Doorduijn J;Federico M;Gaulard P;Gay F;Ghia P;Grønbæk K;Goldschmidt H;Kersten MJ;Kiesewetter B;Landman-Parker J;Le Gouill S;Lenz G;Leppä S;López-Guillermo A;MacIntyre E;Mantega MVM;Moreau P;Moreno C;Nadel B. The EHA Research Roadmap: Malignant Lymphoid Diseases. Hemasphere, 2022, 6, 6, e726-NA 2572-9241 |
Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
The EHA Research Roadmap_EuropeanHematologyAssociation.pdf | 2.55 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License